Skip to main content

bankruptcy

By Jessica Hagen | 12:51 pm | June 16, 2025
Wojcicki, cofounder and former CEO of 23andMe, is set to reacquire the company through her nonprofit, TTAM Research Institute.
By Jessica Hagen | 03:47 pm | February 14, 2024
According to the bankruptcy petition, the company has liabilities of $1 billion to $10 billion and assets of $500 million to $1 billion.
By Jessica Hagen | 03:24 pm | June 13, 2023
The sale comes four months after The Pill Club paid an $18.3 million settlement for alleged Medicaid fraud in California.
By Jessica Hagen | 02:25 pm | April 07, 2023
The prescription digital therapeutics company is pursuing a sale of the business or its assets.
By Emily Olsen | 01:24 pm | February 27, 2023
Lucira's diagnostic is the first over-the-counter at-home combination test for COVID-19 and flu authorized by the FDA.
By Jonah Comstock | 11:07 am | August 20, 2020
After declaring bankruptcy at the beginning of 2019, the Canadian company sold some of its patents to Honeywell.
By HIMSS Media | 03:54 pm | June 26, 2020
What the loss of one of the earliest and most well-known companies in the digital health space tells us about digital health and pharma.
By Dave Muoio | 03:51 pm | June 16, 2020
The news comes months after reports that the company had furloughed staff and couldn't secure additional funding for its-ingestible sensor business.
By Aditi Pai | 01:38 pm | January 18, 2016
About two weeks after reports of it shutting down surfaced, HealthSpot, which offered telemedicine kiosks for workplace and retail locations, has filed for Chapter 7 bankruptcy liquidation, according to a report in Columbia Business First.